VARDENAFIL
- Product NDC
- 71610-643
- Requested package NDC
- 71610-643-02
- 11-digit product format
- 716100643
- Labeler code
- 71610
- Product ID
- 71610-643_872fc6c8-cdb2-4056-a5c8-874389bb6605
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- VARDENAFIL
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Application
- ANDA208960
- Marketing category
- ANDA
- Marketing start
- 2018-10-31
- Marketing end
- 0000-00-00
- Substance
- VARDENAFIL HYDROCHLORIDE TRIHYDRATE
- Active strength
- 20 mg/1
- Pharmacologic classes
- Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status. Browse every current auxiliary row, including rows without a usable NDC. · Browse every captured source and parsed snapshot.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 71610-643 | 71610-643-02 | D | Discontinued by firm | 2026-08-03 |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A208960-001 | VARDENAFIL HYDROCHLORIDE | VARDENAFIL HYDROCHLORIDE | EQ 2.5MG BASE | TABLET / ORAL | AB | 2018-10-31 | |
| A208960-002 | VARDENAFIL HYDROCHLORIDE | VARDENAFIL HYDROCHLORIDE | EQ 5MG BASE | TABLET / ORAL | AB | 2018-10-31 | |
| A208960-003 | VARDENAFIL HYDROCHLORIDE | VARDENAFIL HYDROCHLORIDE | EQ 10MG BASE | TABLET / ORAL | AB | 2018-10-31 | |
| A208960-004 | VARDENAFIL HYDROCHLORIDE | VARDENAFIL HYDROCHLORIDE | EQ 20MG BASE | TABLET / ORAL | AB | RS | 2018-10-31 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A208960-001 | AB |
| A208960-002 | AB |
| A208960-003 | AB |
| A208960-004 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A208960-001 | VARDENAFIL HYDROCHLORIDE | EQ 2.5MG BASE | TABLET / ORAL | AB | 2018-10-31 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A208960-002 | VARDENAFIL HYDROCHLORIDE | EQ 5MG BASE | TABLET / ORAL | AB | 2018-10-31 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A208960-003 | VARDENAFIL HYDROCHLORIDE | EQ 10MG BASE | TABLET / ORAL | AB | 2018-10-31 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A208960-004 | VARDENAFIL HYDROCHLORIDE | EQ 20MG BASE | TABLET / ORAL | AB | RS | 2018-10-31 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A208960-001 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A208960-002 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A208960-003 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A208960-004 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| VARDENAFIL | VARDENAFIL | Zydus Lifesciences Limited | 8ea14f7e-44a0-4d9c-968a-87b97ca12f09 | 2026-01-05 | 208960 ANDA208960 | |
| VARDENAFIL | VARDENAFIL | Zydus Pharmaceuticals USA Inc. | 5876e062-e604-42a7-99c3-5da30b8dac06 | 2026-01-05 | Warnings, Adverse reactions | 208960 ANDA208960 |
| VARDENAFIL | VARDENAFIL | Aphena Pharma Solutions - Tennessee, LLC | c70a9c8e-46b0-489d-bbda-2d7fca4b629f | 2020-11-11 | Warnings, Adverse reactions | 208960 ANDA208960 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 71610-643-02 | EA - Each | 71610-643 | ad8b7bcb-12fe-4eee-aee7-7857537fbce1 | 1 | 2022-06-06 |
| 71610-643-04 | EA - Each | 71610-643 | 2a7969cb-4d66-4ecf-9d32-dc99b622fc5e | 1 | 2022-06-06 |
| 71610-643-06 | EA - Each | 71610-643 | 1c98e139-baa2-4d06-ab70-88ad4c3eb4be | 1 | 2022-06-06 |
| 71610-643-12 | EA - Each | 71610-643 | ae2e5a21-e6f7-403e-92f7-c8ccb40c2b8f | 1 | 2022-06-06 |
DailyMed Dashboard NDC Coverage#
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 71610-643-02 | 71610064302 | 2 TABLET, FILM COATED in 1 BOTTLE (71610-643-02) | 2022-04-21 | 0000-00-00 | No | No | Current |